Bulletin
Investor Alert

New York Markets After Hours

Flexion Therapeutics Inc.

NAS: FLXN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202477643/composite

$

10.40

Change

0.00 0.00%

Volume

Volume 11,735

Sep 29, 2020, 4:42 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202477643/composite

Today's close

$ 10.86

$ 10.40

Change

-0.46 -4.24%

Day low

Day high

$10.23

$10.84

Open
Open: 10.84

52 week low

52 week high

$5.01

$22.98

Open

Market cap

$535.43M

Average volume

561,182

P/E ratio

N/A

Rev. per Employee

$82,809

EPS

-3.60

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/flxn

MarketWatch News on FLXN

  1. Flexion Therapeutics started at outperform with $19 stock price target at Oppenheimer

    8:28 a.m. July 31, 2020

    - Tomi Kilgore

  2. Flexion Therapeutics stock price target cut to $17 from $25 at Benchmark

    6:38 a.m. April 2, 2020

    - Tomi Kilgore

  3. Dow, S&P 500 rise as stocks extend record-setting rally

    5:36 p.m. Dec. 27, 2019

    - Chris Matthews

  4. Flexion Therapeutics stock price target raised to $28 vs. $25 at Raymond James

    8:19 a.m. Dec. 27, 2019

    - Ciara Linnane

  5. Flexion Therapeutics stock price target raised to $25 vs. $19 at Benchmark

    8:03 a.m. Dec. 27, 2019

    - Ciara Linnane

  6. Flexion Therapeutics reiterated as buy at Benchmark

    8:04 a.m. Dec. 27, 2019

    - Ciara Linnane

  7. Flexion Therapeutics' stock tumbles 11% premarket after weak revenue outlook late Thursday

    9:12 a.m. Jan. 4, 2019

    - Tomi Kilgore

  8. Flexion Therapeutics downgraded to hold from buy at Benchmark

    8:53 a.m. Jan. 4, 2019

    - Tomi Kilgore

  9. Flexion shares plummet after weak revenue guidance

    5:36 p.m. Jan. 3, 2019

    - Max A. Cherney

  10. Flexion Therapeutics started at buy with $39 stock price target at Benchmark

    7:55 a.m. June 28, 2018

    - Tomi Kilgore

  11. Flexion shares halted on news of FDA approval for knee pain injection

    3:10 p.m. Oct. 6, 2017

    - Emma Court

  12. Flexion Therapeutics started at strong buy with $35 stock price target at Raymond James

    9:24 a.m. Dec. 22, 2016

    - Tomi Kilgore

  13. ConAgra rallies on earnings; Peabody tops losers

    3:41 p.m. Sept. 18, 2014

    - Sue Chang

  14. United Natural shares surge on earnings, outlook beat

    5:19 p.m. Sept. 17, 2014

    - Wallace Witkowski

Analyst Ratings

/news/nonmarketwatch/company/us/flxn

Other News on FLXN

  1. Flexion Therapeutics (FLXN) Received its Third Buy in a Row

    2:47 p.m. Sept. 21, 2020

    - SmarterAnalyst

  2. Flexion Therapeutics (FLXN) Received its Third Buy in a Row

    12:32 p.m. Aug. 6, 2020

    - SmarterAnalyst

  3. Analyzing Flexion Therapeutics's Unusual Options Activity

    11:27 a.m. Aug. 6, 2020

    - benzinga.com

  4. Flexion Therapeutics (FLXN) Receives a Buy from Oppenheimer

    7:55 a.m. Aug. 6, 2020

    - SmarterAnalyst

  5. Flexion Therapeutics (FLXN) Received its Third Buy in a Row

    7:11 a.m. Aug. 6, 2020

    - SmarterAnalyst

  6. Flexion Therapeutics (FLXN) Received its Third Buy in a Row

    6:26 a.m. Aug. 6, 2020

    - SmarterAnalyst

  7. 10-Q: FLEXION THERAPEUTICS INC

    4:25 p.m. Aug. 5, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. OK Boomer, Flexion Stock Is Made For You

    6:31 a.m. July 24, 2020

    - InvestorPlace.com

  9. BMO Capital Keeps a Buy Rating on Flexion Therapeutics (FLXN)

    5:06 a.m. July 24, 2020

    - SmarterAnalyst

  10. Loading more headlines...
/news/pressrelease/company/us/flxn

Press Releases on FLXN

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.